Estimated glomerular filtration rates through 144 weeks on therapy in HIV-1-infected subjects receiving atazanavir/ritonavir and abacavir/lamivudine or simplified to unboosted atazanavir/abacavir/lamivudine

Benjamin Young, Kathleen E. Squires, Karen Tashima, Keith Henry, Stefan Schneider, Anthony LaMarca, Henry H. Zhao, Lisa L. Ross, Mark S. Shaefer

Research output: Contribution to journalArticlepeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)125-129
Number of pages5
JournalHIV Clinical Trials
Issue number4
StatePublished - Aug 2015


  • Antiretroviral therapy
  • GFR
  • Kidney function
  • Renal impairment

Cite this